Evidence map›Paper›PMID 28701356›Full record

ArticleAmerican journal of physiology. Cell physiology2017

Reciprocal regulation of miR-214 and PTEN by high glucose regulates renal glomerular mesangial and proximal tubular epithelial cell hypertrophy and matrix expansion.

Amit Bera, Falguni Das, Nandini Ghosh-Choudhury, Meenalakshmi M Mariappan, Balakuntalam S Kasinath, Goutam Ghosh Choudhury

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. miRNA in the Progression of Diabetic Kidney Disease: New Insight.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Cell-Based Therapies for Glaucoma.Translational vision science & technology · 2023
    Article
  12. Article
  13. The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy.International journal of molecular sciences · 2023
    Review
  14. Kidney fibrosis: from mechanisms to therapeutic medicines.Signal transduction and targeted therapy · 2023
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Amit BeraDepartment of Medicine, UT Health San Antonio, San Antonio, Texas.
Falguni DasDepartment of Medicine, UT Health San Antonio, San Antonio, Texas.
Nandini Ghosh-ChoudhuryVeterans Affairs Biomedical Laboratory Research, South Texas Veterans Health Care System, San Antonio, Texas.
Meenalakshmi M MariappanDepartment of Medicine, UT Health San Antonio, San Antonio, Texas.
Balakuntalam S KasinathDepartment of Medicine, UT Health San Antonio, San Antonio, Texas.ORCID http://orcid.org/0000-0002-6360-101X
Goutam Ghosh ChoudhuryDepartment of Medicine, UT Health San Antonio, San Antonio, Texas; choudhuryg@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · US

Funding

Mechanisms of Renal Cell InjuryI01BX000926 · VA · SOUTH TEXAS VETERANS HEALTH CARE SYSTEM · PI GHOSH CHOUDHURY, GOUTAM, SHARMA, KUMAR · 2011 to 2024
–
BLRD VA I01 BX000926BLRD VA IK6 BX003611
6 · The paper itself

Abstract

Aberrant expression of microRNAs (miRs) contributes to diabetic renal complications, including renal hypertrophy and matrix protein accumulation. Reduced expression of phosphatase and tensin homolog (PTEN) by hyperglycemia contributes to these processes. We considered involvement of miR in the downregulation of PTEN. In the renal cortex of type 1 diabetic mice, we detected increased expression of miR-214 in association with decreased levels of PTEN and enhanced Akt phosphorylation and fibronectin expression. Mesangial and proximal tubular epithelial cells exposed to high glucose showed augmented expression of miR-214. Mutagenesis studies using 3'-UTR of PTEN in a reporter construct revealed PTEN as a direct target of miR-214, which controls its expression in both of these cells. Overexpression of miR-214 decreased the levels of PTEN and increased Akt activity similar to high glucose and lead to phosphorylation of its substrates glycogen synthase kinase-3β, PRAS40, and tuberin. In contrast, quenching of miR-214 inhibited high-glucose-induced Akt activation and its substrate phosphorylation; these changes were reversed by small interfering RNAs against PTEN. Importantly, respective expression of miR-214 or anti-miR-214 increased or decreased the mammalian target of rapamycin complex 1 (mTORC1) activity induced by high glucose. Furthermore, mTORC1 activity was controlled by miR-214-targeted PTEN via Akt activation. In addition, neutralization of high-glucose-stimulated miR-214 expression significantly inhibited cell hypertrophy and expression of the matrix protein fibronectin. Finally, the anti-miR-214-induced inhibition of these processes was reversed by the expression of constitutively active Akt kinase and hyperactive mTORC1. These results uncover a significant role of miR-214 in the activation of mTORC1 that contributes to high-glucose-induced mesangial and proximal tubular cell hypertrophy and fibronectin expression.

Indexed as

Cell Proliferation3' Untranslated RegionsAnimalsBlood GlucoseCells, CulturedDiabetes Mellitus, Type 1Diabetic NephropathiesDisease Models, AnimalEpithelial CellsFibronectinsGene Expression Regulation, EnzymologicGlomerular MesangiumHypertrophyKidney GlomerulusKidney Tubules, ProximalMechanistic Target of Rapamycin Complex 13' Untranslated RegionsBlood GlucoseFibronectinsMechanistic Target of Rapamycin Complex 1MicroRNAsMirn214 microRNA, mouseMirn214 microRNA, ratMultiprotein ComplexesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePten protein, mousePten protein, ratTOR Serine-Threonine KinasesTransforming Growth Factor betacell hypertrophy and fibrosisdiabetic nephropathymicroRNAmTOR complex 1

Identifiers

PMID28701356
PMCPMC5668576
OpenAlexW2735368759

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.